$LMAT News

LeMaitre Vascular Inc. (NASDAQ:LMAT) Passes the Quality Test with Caviar Cruise Screen

How The LeMaitre Vascular (LMAT) Story Is Shifting As Analysts Lift Fair Value Targets

LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why

1 Reason to Avoid LMAT and 1 Stock to Buy Instead

Winners And Losers Of Q1: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks

LeMaitre to Participate at Upcoming Investor Conferences in June

5 Insightful Analyst Questions From LeMaitre’s Q1 Earnings Call

Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround

LeMaitre Vascular Inc (NASDAQ:LMAT): A Quality Investing Candidate Passing All Caviar Cruise Screen Tests

Insider Transaction: George LeMaitre Sells $5.03M Worth Of LeMaitre Vascular Shares

US$118 - That's What Analysts Think LeMaitre Vascular, Inc. (NASDAQ:LMAT) Is Worth After These Results

3 Reasons Growth Investors Will Love LeMaitre (LMAT)

LeMaitre (LMAT) Upgraded to Buy: Here's Why

Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $120

LeMaitre Vascular, Inc. Q1 2026 Earnings Call Summary

Citizens Maintains Market Outperform on LeMaitre Vascular, Raises Price Target to $127

Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Raises Price Target to $104

LeMaitre Vascular Q1 Earnings Call Highlights

LeMaitre Vascular, Inc. (LMAT) Q1 2026 Earnings Call Transcript

LeMaitre Vascular (NASDAQ:LMAT) Reports Steady Q1 2026 Results with Earnings Beat and In-Line Revenue